Mauna Kea Technologies postpones release of its 2022 Half-Year Results, which was originally planned for September 22, 2022, to not later than October 31, 2022. The delay reflects the diversion of management resources as required to implement the Company's previously announced joint venture with Tasly Pharmaceutical. The company will release its new financial calendar shortly.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.38 EUR | +0.13% | -3.55% | -19.32% |
Apr. 03 | Mauna Kea: first Italian center for Cellvizio | CF |
Mar. 27 | Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.32% | 24.96M | |
-13.87% | 19.18B | |
-44.61% | 2.73B | |
+16.10% | 1.84B | |
-3.24% | 1.61B | |
+21.91% | 1.18B | |
-21.52% | 898M | |
-12.00% | 710M | |
-16.68% | 694M | |
+12.50% | 526M |
- Stock Market
- Equities
- ALMKT Stock
- News Mauna Kea Technologies
- Mauna Kea Technologies Postpones Release of its 2022 Half-Year Financial Results